Brian Tyler

Brian Tyler leads McKesson Corporation, the largest company in the US healthcare supply chain with annual revenue exceeding $300 billion — making it one of the five largest companies in America by revenue, though its low-profile distribution business makes it relatively unknown to consumers. McKesson distributes approximately one-third of all prescription drugs sold in the United States, connecting pharmaceutical manufacturers with over 40,000 pharmacies, hospitals, and health systems. McKesson's distribution model generates thin margins on enormous volume — but incremental margin improvements on $300+ billion of revenue translate into substantial profit. Beyond distribution, Tyler has invested in higher-margin businesses: oncology and specialty drug distribution (where McKesson holds a leading position through US Oncology Network), pharmaceutical technology solutions, and biopharma services. The GLP-1 obesity drug boom (Ozempic, Wegovy) has been a meaningful volume tailwind for McKesson's distribution network. Tyler's execution on specialty drug distribution growth, margin expansion, and capital return through aggressive share repurchases are the primary drivers of the stock.